TLR4 and influenza: Toll-like receptor 4 (TLR4) agonists, such as monophosphoryl lipid A (MPL) or glucopyranosyl lipid adjuvant (GLA), when combined with alum or in oil-in-water formulation, also exhibited potential for use as adjuvant for influenza vaccines [7, 8].